We describe a case of Trichosporon asahii late-onset sepsis in an extremely low birth weight infant from our neonatal intensive care unit. The baby presented early neutropenia and received therapy with granulocyte colony-stimulating factor. At day of life 8 he showed clinical signs of sepsis. Forty-eight hours after beginning of symptoms, blood culture developed T. asahii. Baby responded to treatment with liposomal amphotericin B. The aim of this report is to discuss a case of late onset sepsis in an immuno-compromised patient due to an unusual pathogen, with variable or intrinsic resistance to the most commonly used antifungal therapies. Appropriate use of antifungal in this vulnerable population is of pivotal importance for both treatment and prevention of infection.
8 in 6 newborns. Conclusions: Pharmacokinetic parameters of gentamicin are predictable in term newborn infants. With gentamicin doses normally used Cmax/MIC values reached 8 in 6 newborns. It is necessary to review the usefulness of plasma drug monitoring and gentamicin dosage in this group of newborns.]]>
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.